"Now if we do a really good job on healthcare, new vaccines... we could lower that (the world population) perhaps by 10 or 15%"
He told us years ago. But the audience was laughing. Because no one believed he meant it literally.
"Máme spolehlivé důkazy, že 0.1% obivatelstva umřela buť s a nebo kvuli Covidu, pravděbodobně s Covidem. A 50% populace se zbláznila. Jenom si zrovnejte čísla, jsou dokonce v logaritmickym poměru mnohonásobně od sebe!"
"Ve spojeních státu Ameriky, podle studii od Christakise, kteriho uplně zkritizovaly, bylo straceno vice než 5 milionu roku života zduvodu zavřenich škol, což je o mnoho víc, než stráta životu spusobení Corona virem."
Click on the links to access the following studies referenced by Dr. Stock:
1. SARS-CoV2-Transmission Among Marine Recruits during Quarantine.
https://www.nejm.org/doi/full/10.1056/NEJMoa2029717
2. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.
https://pubmed.ncbi.nlm.nih.gov/33948610/
3. Vitamin D for prevention of respiratory tract infections: A systematic review and meta-analysis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543548/
4. Facemasks in the COVID-19 era: A health hypothesis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680614/
5. CDC assessment of non-pharmaceutical influenza methods.
https://wwwnc.cdc.gov/eid/article/26/5/19-0994_article
6. Federalist cases/mortality mask comparison
https://thefederalist.com/2020/10/29/these-12-graphs-show-mask-mandates-do-nothing-to-stop-covid/
7. Heritage Foundation Study – In fact, mask use during the pandemic has been recommended by The Heritage Foundation’s Coronavirus Commission guidelines. However, our findings do suggest that public health strategies relying predominantly on mask mandates are inadequate, and thus other initiatives, in addition to mask wearing, should have been a component of policies aimed to limit the spread of the disease.
https://www.heritage.org/government-regulation/report/statistical-analysis-mandates-and-mask-usage-kansas
8. Declaration of Great Barrington– The Great Barrington Declaration- As infectious disease epidemiologists and public health scientists we have grave concerns about the damaging physical and mental health impacts of the prevailing COVID-19 policies, and recommend an approach we call Focused Protection. Over 60,000 medical experts have signed this declaration.
https://gbdeclaration.org/
https://gbdeclaration.org/view-signatures/
9. Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
https://www.nejm.org/doi/full/10.1056/NEJMoa2109072
10. Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study
https://www.mdpi.com/2072-6643/13/6/1760
11. Experimental Assessment of Carbon Dioxide Content in Inhaled Air With or Without Face Masks in Healthy Children.
https://jamanetwork.com/journals/jamapediatrics/fullarticle/2781743
12. Calcifediol treatment and COVID-19-related outcomes
https://pubmed.ncbi.nlm.nih.gov/34097036/
13. “Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study.
https://www.sciencedirect.com/science/article/abs/pii/S0960076020302764
14. Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers
https://pubmed.ncbi.nlm.nih.gov/33205991/
15. Community Use Of Face Masks And COVID-19: Evidence From A Natural Experiment Of State Mandates In The US
https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.00818
16. Face-Masks in the COVID-19 era: A health hypothesis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680614/
This article has been retracted
17. Infection Fatality Ratios for COVID-19 Among Non-Institutionalized Persons 12 and Older: Results of a Random-Sample Prevalence Study
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505013/
18. Open Schools, COVID-19, and Child and Teacher Morbidity in Sweden.
https://pubmed.ncbi.nlm.nih.gov/20092668/
19. Face-Masks to prevent transmission of influenza virus: a systematic review
https://pubmed.ncbi.nlm.nih.gov/20092668/
20. Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gathering- Barnstable County, Massachusetts, July 2021
https://www.cdc.gov/mmwr/volumes/70/wr/mm7031e2.htm
21. Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomized, placebo-controlled, study
https://pmj.bmj.com/content/early/2020/11/12/postgradmedj-2020-139065
22. Rapid Expert Consultation on the Effectiveness of Fabric Masks for the COVID-19 Pandemic (April 8, 2020)
https://www.ncbi.nlm.nih.gov/books/NBK556964/
Covid-19 Treatment Protocol
Dr. Vladimir Zelenko
www.VladimirZelenkoMD.com
Fundamental Principles
Treat patients based on clinical suspicion as soon as possible, preferably within the first 5 days
of symptoms. Perform PCR testing, but do not withhold treatment pending results.
Risk Stratify Patients
Low risk patient - Younger than 45, no comorbidities, and clinically stable
High risk patient - Older than 45, younger than 45 with comorbidities, or clinically unstable
Treatment Options
Low risk patients
Supportive care with fluids, fever control, and rest
Elemental Zinc 50mg 1 time a day for 7 days
Vitamin C 1000mg 1 time a day for 7 days
Vitamin D3 5000iu 1 time a day for 7 days
Optional over the counter options
Quercetin 500mg 2 times a day for 7 days or
Epigallocatechin-gallate (EGCG) 400mg 1 time a day for 7 daysModerate / High risk patients
Elemental Zinc 50-100mg once a day for 7 days
Vitamin C 1000mg 1 time a day for 7 days
Vitamin D3 10000iu once a day for 7 days or 50000iu once a day for 1-2 days
Azithromycin 500mg 1 time a day for 5 days or
Doxycycline 100mg 2 times a day for 7 days
Hydroxychloroquine (HCQ) 200mg 2 times a day for 5-7 days
and/or
Ivermectin 0.4-0.5mg/kg/day for 5-7 days
Either or both HCQ and IVM can be used, and if one only, the second agent may be added after
about 2 days of treatment if obvious recovery has not yet been observed etc.
Other treatment options
Dexamethasone 6-12mg 1 time a day for 7 days or
Prednisone 20mg twice a day for 7 days, taper as needed
Budesonide 1mg/2cc solution via nebulizer twice a day for 7 days
Blood thinners (i.e. Lovenox, Eliquis, Xarelto, Pradaxa, Aspirin)
Colchicine 0.6mg 2-3 times a day for 5-7 days
Monoclonal antibodies
Home IV fluids and oxygenTRY TO KEEP PATIENTS OUT OF THE HOSPITAL
1.https://www.sciencedirect.com/science/article/pii/S0924857920304258
2.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365891/
3.https://pubs.acs.org/doi/10.1021/jf5014633
4.https://vdmeta.com/
5.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318306/
6.https://pubs.acs.org/doi/10.1021/jf5014633
7.https://www.sciencedirect.com/science/article/pii/S0924857920304258
8.https://ivmmeta.com/
9.https://www.nejm.org/doi/full/10.1056/NEJMoa2021436
10.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392554/
11. https://www.medrxiv.org/content/10.1101/2021.01.26.21250494v1
Co je to antibody dependent enhancement (ADE)?
Stručně řečeno, jde o to, že vakcína způsobí, že virus se stane infekčnějším, než by se stalo bez očkování. To by způsobilo, že by se virus replikoval ve vyšší míře než v případě absence očkování. To je nejhorší noční můra vakcinologů. Stalo se to s respiračním syncytiálním virem v 60. letech a způsobilo to více úmrtí dětí mezi očkovanými než neočkovanými. Stalo se to s Dengvaxií, vakcínou proti horečce dengue, a stalo se to prakticky s každým dalším vývojovým programem vakcíny Corona známým v historii, rozhodně u lidí.